DNTH
Dianthus Therapeutics Inc.
$34.03
-$0.95(-2.72%)
51
Overall
60
Value
60
Tech
34
Quality
Market Cap
$1.06B
Volume
590.25K
52W Range
$13.37 - $40.16
Target Price
$63.45
EPS Estimates Overview
| Current Quarter | $-0.86 | Next Quarter | $-0.81 |
| Current Year | $-3.41 | Next Year | $-3.56 |
| QoQ Growth | +5.8% | YoY Growth | -4.4% |
| 3Y EPS CAGR | +50.2% | Target Price | $63.45 |
| Consensus | Buy | Upside | +86.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $34.03 | -2.7% | 590.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW